This bill enacts R.S. 22:1076.1, establishing an advisory board within the Louisiana Department of Insurance to review and provide medical recommendations for new treatments for rare cancers. The board will consist of various members, including representatives from the Louisiana Department of Health, the Louisiana Association of Health Plans, and several medical institutions specializing in oncology. Additionally, the board will include two oncologists who focus on rare cancer treatments.

The advisory board is required to hold quarterly public meetings and must compile and submit a formal written report of its findings to the legislature within thirty days of each meeting. The commissioner of the Department of Insurance is also authorized to create administrative rules and regulations necessary for implementing the provisions of this new section.